StockData
Biomea Fusion, Inc. logo

Biomea Fusion, Inc. (BMEA) income statement

BMEANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$0.53+0.04 (+8.61%)

Close on Nov 18, 2026Market cap $38.42MP/E –Yield –

See a number that looks wrong?